BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33391975)

  • 1. Intraoperative assessment and postsurgical treatment of prostate cancer tumors using tumor-targeted nanoprobes.
    Teh J; Tripathi M; Reichel D; Sagong B; Montoya R; Zhang Y; Wagner S; Saouaf R; Chung LWK; Perez JM
    Nanotheranostics; 2021; 5(1):57-72. PubMed ID: 33391975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma.
    Reichel D; Sagong B; Teh J; Zhang Y; Wagner S; Wang H; Chung LWK; Butte P; Black KL; Yu JS; Perez JM
    ACS Nano; 2020 Jul; 14(7):8392-8408. PubMed ID: 32551496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Gastrin-Releasing Peptide Receptor Targeted Near-Infrared Fluorescence Dye for Image-Guided Surgery of Prostate Cancer.
    Pagoto A; Garello F; Marini GM; Tripepi M; Arena F; Bardini P; Stefania R; Lanzardo S; Valbusa G; Porpiglia F; Manfredi M; Aime S; Terreno E
    Mol Imaging Biol; 2020 Feb; 22(1):85-93. PubMed ID: 31025163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid formulation of near infrared fluorophores optimizes surgical imaging in a prostate tumor xenograft.
    Souchek JJ; Wojtynek NE; Payne WM; Holmes MB; Dutta S; Qi B; Datta K; LaGrange CA; Mohs AM
    Acta Biomater; 2018 Jul; 75():323-333. PubMed ID: 29890268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
    Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
    J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye-monoamine oxidase A inhibitor conjugate.
    Lv Q; Yang X; Wang M; Yang J; Qin Z; Kan Q; Zhang H; Wang Y; Wang D; He Z
    J Control Release; 2018 Jun; 279():234-242. PubMed ID: 29679664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor.
    Wu JB; Shi C; Chu GC; Xu Q; Zhang Y; Li Q; Yu JS; Zhau HE; Chung LW
    Biomaterials; 2015 Oct; 67():1-10. PubMed ID: 26197410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Mitochondria-Targeting Fluorophore with Multifunctional Therapeutic Activities against Prostate Cancer via the HIF1α/OATPs Pathway.
    Qin J; Zhang C; Zhao Y; Tan D; Wu P; Shui X; Qin W; Ge X; Shi C
    Mol Pharm; 2023 Dec; 20(12):6226-6236. PubMed ID: 37955533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer.
    Lütje S; Rijpkema M; Goldenberg DM; van Rij CM; Sharkey RM; McBride WJ; Franssen GM; Frielink C; Helfrich W; Oyen WJ; Boerman OC
    Cancer Res; 2014 Nov; 74(21):6216-23. PubMed ID: 25252911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Activatable Clinical Nanoprobe for Cancer Imaging.
    Reichel D; Tripathi M; Butte P; Saouaf R; Perez JM
    Nanotheranostics; 2019; 3(2):196-211. PubMed ID: 31183314
    [No Abstract]   [Full Text] [Related]  

  • 11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A targeted near-infrared nanoprobe for deep-tissue penetration and imaging of prostate cancer.
    Asha Krishnan M; Yadav K; Roach P; Chelvam V
    Biomater Sci; 2021 Mar; 9(6):2295-2312. PubMed ID: 33554988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sight and switch off: Nerve density visualization for interventions targeting nerves in prostate cancer.
    You H; Shang W; Min X; Weinreb J; Li Q; Leapman M; Wang L; Tian J
    Sci Adv; 2020 Feb; 6(6):eaax6040. PubMed ID: 32076639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models.
    Zhang M; Kobayashi N; Zettlitz KA; Kono EA; Yamashiro JM; Tsai WK; Jiang ZK; Tran CP; Wang C; Guan J; Wu AM; Reiter RE
    Clin Cancer Res; 2019 Jan; 25(1):188-200. PubMed ID: 30301826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody.
    Zettlitz KA; Tsai WK; Knowles SM; Kobayashi N; Donahue TR; Reiter RE; Wu AM
    J Nucl Med; 2018 Sep; 59(9):1398-1405. PubMed ID: 29602820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study.
    Ramanathan RK; Korn RL; Raghunand N; Sachdev JC; Newbold RG; Jameson G; Fetterly GJ; Prey J; Klinz SG; Kim J; Cain J; Hendriks BS; Drummond DC; Bayever E; Fitzgerald JB
    Clin Cancer Res; 2017 Jul; 23(14):3638-3648. PubMed ID: 28159813
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging.
    Tian Y; Shen H; Li L; Jia X; Liu J; Hu Z; Wang L; Tian J
    Eur J Nucl Med Mol Imaging; 2024 Apr; ():. PubMed ID: 38647671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation of ferumoxytol by ionizing radiation releases iron. An electron paramagnetic resonance study.
    Petronek MS; Spitz DR; Buettner GR; Allen BG
    J Radiat Res; 2022 May; 63(3):378-384. PubMed ID: 35301531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP.
    Zhu B; Wu G; Robinson H; Wilganowski N; Hall MA; Ghosh SC; Pinkston KL; Azhdarinia A; Harvey BR; Sevick-Muraca EM
    Mol Imaging Biol; 2013 Oct; 15(5):560-8. PubMed ID: 23619897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane dual-targeting probes: A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection.
    Wu LL; Zhao Q; Wang Q; Zhang Q; Yang F; Zheng B; Hu HY; Xing N
    Acta Pharm Sin B; 2023 Mar; 13(3):1204-1215. PubMed ID: 36970202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.